All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @theonlybigb on Instagram · 20s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @theonlybigb's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:01Ooh, okay.
  2. 0:03Man, what's she at?
  3. 0:05Ben, where you at?
  4. 0:08I can't hear you.
  5. 0:09Where did it go?

@theonlybigb's testosterone symptoms claim, fact-checked

Brian Jenkins 🔥CELEBRITY TRAINER

Instagram creator

7.0K viewsView on Instagram →

Quick answer

The caption's symptom list aligns with established hypogonadism criteria per Bhasin et al. (2010), but the claim that PCPs will not test for low testosterone overstates a real access gap in a way that may push men toward testosterone prescribers before ruling out thyroid dysfunction, sleep apnea, depression, or other reversible causes. A complete hypogonadism workup requires morning total and free testosterone confirmed on two separate draws, plus LH, FSH, and SHBG, not a single panel. The actual transcript contains no clinical content and cannot be independently fact-checked.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @theonlybigb's testosterone symptoms claim, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@theonlybigb's testosterone symptoms claim, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@theonlybigb's testosterone symptoms claim, fact-checked" from Brian Jenkins 🔥CELEBRITY TRAINER. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The caption's symptom list aligns with established hypogonadism criteria per Bhasin et al.

The reason this review is not generic is the source wording and the canonical claim label "trt fellas over the age of 35 if you re feeling any of the foll." In this clip, the useful excerpt is: "Ooh, okay." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Harman et al.
People who land here are usually trying to understand whether the Testosterone claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The caption's symptom list aligns with established hypogonadism criteria per Bhasin et al.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The caption's symptom list aligns with established hypogonadism criteria per Bhasin et al. (2010), but the claim that PCPs will not test for low testosterone overstates a real access gap in a way that may push men toward testosterone prescribers before ruling out thyroid dysfunction, sleep apnea, depression, or other reversible causes. A complete hypogonadism workup requires morning total and free testosterone confirmed on two separate draws, plus LH, FSH, and SHBG, not a single panel. The actual transcript contains no clinical content and cannot be independently fact-checked.
  • The Endocrine Society requires two separate morning testosterone draws to confirm hypogonadism before any treatment is initiated, not a single panel.
  • Harman et al. (2001, JCEM) found testosterone declines roughly 1-2% per year after age 30, making age 35 a reasonable point to establish a baseline.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The Endocrine Society requires two separate morning testosterone draws to confirm hypogonadism before any treatment is initiated, not a single panel.
  • Harman et al. (2001, JCEM) found testosterone declines roughly 1-2% per year after age 30, making age 35 a reasonable point to establish a baseline.
  • Hair loss is driven by DHT sensitivity, not low testosterone. TRT can worsen androgenic alopecia in men who are genetically predisposed.
  • A complete workup should include total testosterone, free testosterone, LH, FSH, SHBG, prolactin, and CBC. Skipping LH and FSH means missing whether the problem originates in the testes or the pituitary.
  • Snyder et al. (2016, NEJM) found modest benefits of TRT in older men with low levels but also identified a cardiovascular signal that remains under active investigation. TRT is not risk-free.
  • PCPs undertest for hypogonadism, but the fix is asking for a complete panel, not bypassing primary care entirely. Sleep apnea, thyroid dysfunction, and depression can mimic every symptom on this list.
  • Irritability and fatigue are among the least specific symptoms on the list. A responsible clinician rules out mental health conditions and sleep disorders before attributing them to low testosterone.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @theonlybigb actually say?

Here's the awkward truth: the transcript we have is just audio confusion. "Ooh, okay. Man, what's she at? Ben, where you at? I can't hear you. Where did it go?" That's it. The actual claims live in the caption, not the spoken word.

The caption is doing real work here. It lists fatigue, erectile dysfunction, muscle loss, low sex drive, irritability, hair loss, and weight gain as symptoms that should prompt hormone testing. Then it makes a specific procedural claim: "Your primary care physician is not going to test for this at your annual physical." That's the line worth examining. The symptom list is broadly consistent with hypogonadism literature. The PCP claim is more complicated.

Does the science back this up?

The symptom cluster is legitimate. The PCP claim is partially true but oversimplified in a way that could push men toward direct-to-consumer testosterone before they've had a real workup.

The symptoms listed map closely to what the American Urological Association and Endocrine Society recognize as signs of hypogonadism. Bhasin et al. (2010, Journal of Clinical Endocrinology and Metabolism) established that fatigue, reduced libido, erectile dysfunction, and body composition changes are cardinal symptoms warranting testosterone measurement. That part checks out.

The PCP gap is real but not universal. A 2020 study by Mulhall et al. in the Journal of Urology found that testosterone testing rates in primary care are genuinely low, particularly for men under 50. But "not going to test" is an overstatement. Many PCPs will order a morning total testosterone if you ask. The problem is they often stop there, skipping free testosterone, LH, FSH, and SHBG, which are necessary to understand why levels are low.

What did they get wrong (or right)?

The symptom list is mostly right. The PCP framing is misleading by omission, and that matters clinically.

Credit where it's due: normalizing conversations about male hormonal health is genuinely useful. Men are underscreened. The stigma around ED and fatigue keeps a lot of guys from mentioning symptoms at all. Raising awareness has value.

But "your PCP is not going to test for this" slides from a real systemic problem into an implicit sales pitch. It primes men to bypass primary care entirely and go straight to telehealth testosterone prescribers, some of whom have financial incentives to prescribe. Hair loss, for example, is listed as a testosterone-related symptom, but androgenic alopecia is actually associated with DHT sensitivity, not low testosterone per se. Prescribing testosterone without checking DHT conversion can accelerate hair loss, not fix it. Irritability is real but nonspecific: it shows up in sleep apnea, thyroid disorders, depression, and low testosterone alike. A responsible workup rules those out first.

  • Hair loss listed as a low-T symptom is an oversimplification
  • Irritability requires differential diagnosis, not a hormone panel alone
  • The PCP framing discourages a complete workup rather than encouraging one

What should you actually know?

If you have these symptoms, get blood work. But get the right blood work, ideally through someone who will look at the full picture before prescribing anything.

A proper hypogonadism workup includes morning total testosterone (tested twice on separate days), free testosterone, LH, FSH, SHBG, prolactin, and a CBC. The Endocrine Society recommends confirming low testosterone on two separate morning samples before initiating treatment. One number on one day is not a diagnosis.

TRT is a legitimate, FDA-approved treatment for confirmed hypogonadism. But the threshold matters. Some telehealth platforms prescribe at levels that many endocrinologists would consider low-normal rather than deficient. Snyder et al. (2016, New England Journal of Medicine) showed modest benefits of testosterone in older men with low levels, but also flagged cardiovascular signal concerns that are still being studied. This is not a risk-free intervention.

If your PCP won't run a full panel, ask specifically for the tests listed above. If they still won't, a referral to an endocrinologist or urologist is the next step, not necessarily a subscription service.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Brian Jenkins 🔥CELEBRITY TRAINER · Instagram creator

7.0K views on this video

Fellas over the age of 35, if you’re feeling any of the following…👇🏾 Fatigue Erectile Dysfunction Muscle loss Low sex drive Irritability Hair loss Weight/Fat gain . It’s time to get your hormones c

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about the endocrine society requires two separate morning testosterone draws to?

The Endocrine Society requires two separate morning testosterone draws to confirm hypogonadism before any treatment is initiated, not a single panel.

What does the video say about harman et al. (2001, jcem) found testosterone declines roughly 1-2%?

Harman et al. (2001, JCEM) found testosterone declines roughly 1-2% per year after age 30, making age 35 a reasonable point to establish a baseline.

What does the video say about hair loss?

Hair loss is driven by DHT sensitivity, not low testosterone. TRT can worsen androgenic alopecia in men who are genetically predisposed.

What does the video say about a complete workup should include total testosterone, free testosterone, lh,?

A complete workup should include total testosterone, free testosterone, LH, FSH, SHBG, prolactin, and CBC. Skipping LH and FSH means missing whether the problem originates in the testes or the pituitary.

What does the video say about snyder et al. (2016, nejm) found modest benefits of trt?

Snyder et al. (2016, NEJM) found modest benefits of TRT in older men with low levels but also identified a cardiovascular signal that remains under active investigation. TRT is not risk-free.

What does the video say about pcps undertest for hypogonadism,?

PCPs undertest for hypogonadism, but the fix is asking for a complete panel, not bypassing primary care entirely. Sleep apnea, thyroid dysfunction, and depression can mimic every symptom on this list.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Brian Jenkins 🔥CELEBRITY TRAINER, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.